SCHEMBL14327598

SCHEMBL14327598

CCc1cnc(-c2c[nH]c3ncc(Cl)cc23)nc1N1CCSC1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.38
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2633718 0.71 JAK2 (0.44) JAK2
SCHEMBL14465247 0.71 MEN1 (0.51) —
SCHEMBL14236254 0.70 LATS1 (0.41) —
SCHEMBL14327604 0.69 JAK2 (0.40) JAK2MAPK1
SCHEMBL8943361 0.69 JAK2 (0.49) JAK2
SCHEMBL18052018 0.69 JAK2 (0.44) JAK2
SCHEMBL15998701 0.68 JAK2 (0.48) JAK2
SCHEMBL18052074 0.68 — —
SCHEMBL18052006 0.68 — —
SCHEMBL10304023 0.68 MAP3K11 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2537849-A2 Azaindoles useful as inhibitors of janus kinases Vertex Pharmaceuticals, Inc. (US) 2012-12-26 — — EP disclosed
Send feedback